Stimulating the Immune System With Coxsackievirus in Advanced Cancer Patients

May 27, 2017
Charles M. Rudin, MD, PhD

Charles M. Rudin, MD, PhD, chief, thoracic oncology, Memorial Sloan Kettering Cancer, discusses a study of intravenously delivered coxsackievirus A21 with pembrolizumab to treat patients with advanced cancers.